Naphazoline Hydrochloride/Neostigmine methylsulfate/Glycyrrhizinate dipotassium/Chlorphenamine Maleate/Aspartic Acid/Vitamin B6

盐酸萘甲唑啉/甲硫酸新斯的明/甘草酸二钾/马来酸氯苯那敏/天门冬氨酸/维生素B6

Report date: 2023/08/09 18:30:04

Base Information

Drug NameNaphazoline Hydrochloride/Neostigmine methylsulfate/Glycyrrhizinate dipotassium/Chlorphenamine Maleate/Aspartic Acid/Vitamin B6
Drug Alias Name复方门冬维甘滴眼液新乐敦
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor agonistsAcetylcholinesterase inhibitorsMuscle relaxation antagonists +[5] 
TargetsAlpha adrenergic receptorAcetylcholinesteraseCorticosteroid 11-beta-dehydrogenase isozyme 1 +[4] 
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Naphazoline HydrochlorideNeostigmine methylsulfateGlycyrrhizinate dipotassium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A